百特醫療產品BAX
紐約證券 · USD
21.96
+0.20
(+0.92%)
收盤 08/02 03:59 (UTC+8)
盤後
21.97
+0.01
(+0.05%)
08/02 03:59 (UTC+8)
百特醫療產品BAX
21.96
+0.20
(+0.92%)
財務數據
損益表
- 43.52
- 36.49
- 37.07
- 37.08
- 71.79
- 35.92
- 49.14
- 4.79
- 27.53
- 26.25
- 6.82
- -6.12
- 1.59
- 0.03
- 93.61
- -49.97
- 36.80
- -90.25
- 474.74
- -4.65
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 2,625,000 | 2,753,000 | 479,000 | 4,914,000 | 3,592,000 | 7,179,000 | 3,708,000 | 3,707,000 | 3,649,000 | 4,352,000 |
營業成本 | 1,764,000 | 1,794,000 | 272,000 | 3,057,000 | 2,205,000 | 5,254,000 | 2,591,000 | 2,596,000 | 2,302,000 | 2,633,000 |
營業毛利 | 861,000 | 959,000 | 207,000 | 1,857,000 | 1,387,000 | 1,925,000 | 1,117,000 | 1,111,000 | 1,347,000 | 1,719,000 |
營業費用 | 803,000 | - | - | - | - | 1,938,000 | 1,168,000 | 1,128,000 | 1,161,000 | 1,129,000 |
研發費用 | 140,000 | 211,000 | 30,000 | 229,000 | 176,000 | 276,000 | 166,000 | 165,000 | 164,000 | 157,000 |
推銷及管理費用 | 663,000 | 758,000 | 153,000 | 1,318,000 | 1,024,000 | 1,662,000 | 1,002,000 | 963,000 | 997,000 | 945,000 |
非經常性項目費用 | - | 425,000 | -430,000 | 430,000 | - | - | - | - | - | 27,000 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 58,000 | -435,000 | 454,000 | -120,000 | 187,000 | -13,000 | -51,000 | -17,000 | 186,000 | 590,000 |
其他收入及費用 | 3,000 | 4,000 | 7,000 | 18,000 | 7,000 | -36,000 | 7,000 | -42,000 | 1,000 | -14,000 |
利息費用 | 64,000 | 90,000 | 88,000 | 85,000 | 78,000 | 75,000 | 128,000 | 124,000 | 117,000 | 117,000 |
稅前純益 | -3,000 | -521,000 | 373,000 | -187,000 | 116,000 | -124,000 | -172,000 | -183,000 | 70,000 | 459,000 |
所得稅 | -67,000 | -33,000 | -61,000 | 91,000 | 77,000 | -93,000 | -223,000 | 10,000 | 25,000 | 82,000 |
稅後純益 | 126,000 | -512,000 | 140,000 | -314,000 | 37,000 | 245,000 | 2,508,000 | -141,000 | 44,000 | 181,000 |
基本每股稅後盈餘(元) | 0.25 | -0.99 | 0.27 | -0.62 | 0.07 | 0.48 | 4.95 | -0.28 | 0.09 | 0.36 |
稀釋每股稅後盈餘(元) | 0.25 | -1.00 | 0.27 | -0.61 | 0.07 | 0.47 | 4.95 | -0.28 | 0.09 | 0.37 |
基本平均股數(千股) | 512000.00 | 512000.00 | 510000.00 | 510000.00 | 508000.00 | 507000.00 | 507000.00 | 506000.00 | 505000.00 | 504000.00 |
稀釋平均股數(千股) | 514000.00 | 508000.00 | 512000.00 | 510000.00 | 510000.00 | 509000.00 | 509000.00 | 506000.00 | 505000.00 | 507000.00 |
還原基本每股稅後盈餘(元) | 0.25 | -0.99 | 0.27 | -0.62 | 0.07 | 0.48 | 4.95 | -0.28 | 0.09 | 0.36 |
還原稀釋每股稅後盈餘(元) | 0.25 | -1.00 | 0.27 | -0.61 | 0.07 | 0.47 | 4.95 | -0.28 | 0.09 | 0.37 |
還原基本平均股數(千股) | 512,000 | 512,000 | 510,000 | 510,000 | 508,000 | 507,000 | 507,000 | 506,000 | 505,000 | 504,000 |
還原稀釋平均股數(千股) | 514,000 | 508,000 | 512,000 | 510,000 | 510,000 | 509,000 | 509,000 | 506,000 | 505,000 | 507,000 |
EBITDA(千元) | 370,000 | -210,000 | 296,000 | 214,000 | 527,000 | 770,000 | 2,724,000 | 308,000 | 505,000 | 729,000 |